India Government Confident Of COVID Vaccine Soon

Henrietta Brewer
July 7, 2020

Exuding confidence over India's technological developments, the ministry of Science and Technology said, "In the past years, India has emerged as one of the significant vaccine manufacturing hubs".

The Drug Controller General of India recently granted permission to initiate Phase I & II human clinical trials for COVID-19 Vaccine Covaxin- being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV). Two of the 11 candidates that have entered human trials are Indian - Covaxin of Bharat Biotech and ZyCov-D of Zydus Pharma. India is now working on more than seven vaccines, and this week, two candidate groups have been approved to begin human clinical trials of their prototypes.

Given that the coronavirus is spreading in the country at an exponential rate, people are waiting for the vaccine to be available soon.

Indian institutions have also engaged in R&D for the development of vaccines in India. It sent a letter to 12 hospitals selected for conducting clinical trials on the indigenously developed candidate COVAXIN and had asked for clinical trials to be fast-tracked and volunteers be enroled, by July 7.

Some of the vaccine development efforts that began several months ago are now in the third and final stage of testing on humans.

In its effort to accelerate development of a vaccine against Covid-19, the Indian government is facing criticism for binding itself with a near-impossible deadline. We have not said that we will launch a vaccine by then. The letter, which did the rounds on social media, also carried a.

The ICMR released a subsequent statement on Saturday to argue that the letter was aimed at cutting unnecessary red tape without bypassing any necessary process.

The country has registered more than 720,000 Covid-19 cases and is now third on the list of countries with the most infections. Developing a vaccine is a complicated procedure that involves proving its effectiveness and safety, he said. The indigenous, inactivated vaccine has been developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) High Containment Facility located in Genome Valley, Hyderabad, the company said.

The possibility of having a COVID-19 vaccine ready for public use by August 15 had raised concerns over potential lapses in clinical tests due to the hurry.

In animal studies, the vaccine was found to obtain a strong immune response in various animal species (such as guinea pigs, mice, rats, and rabbits).

Other reports by iNewsToday